stars 1 stars 2 stars 3

About MicrocynVS® The MicrocynVS® family of animal healthcare products are the ONLY animal healthcare products with the original Microcyn® Technology formulated exclusively for North American veterinarians. With over ten million creatures successfully treated with Microcyn® Technology—both four-legged and two—there has never been a single report of a serious adverse effect. It is a superior hypochlorous acid solution that is clinically proven safe, non-toxic and effective. Can safely be used around the nose, eyes, ears and mouth and requires no mixing or dilution. About Sonoma Pharmaceuticals, Inc. Sonoma Pharmaceuticals is a specialty pharmaceutical company that develops and markets unique and effective solutions for the treatment of dermatological conditions and advanced tissue care. The company’s products, which are sold throughout the United States and internationally, have improved outcomes for more than five million patients globally by reducing infections, itch, pain, scarring and harmful inflammatory responses. The company’s headquarters are in Petaluma, California, with manufacturing operations in the United States and Latin America. European marketing and sales are headquartered in Roermond, Netherlands.

MicrocynVS Questions

The MicrocynVS annual revenue was $3 million in 2026.

MicrocynVS is based in Petaluma, California.

The NAICS codes for MicrocynVS are [32541, 325, 3254, 32].

The SIC codes for MicrocynVS are [2834, 28, 283].

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users